Dental Implants and Prosthetics: approx. 60%
Orthodontics: approx. 25%
Digital Solutions and Services: approx. 15%

TOP 3 Markets:

1. Europe: approx. 40%
2. North America: approx. 30%
3. Asia-Pacific: approx. 20%

Straumann Holding AG generates the majority of its revenue from the dental implants and prosthetics sector, which is attributed to its strong market position and innovation in this segment. Orthodontics and digital solutions complement the portfolio and also contribute significantly to the revenue.

Geographically, Europe is the largest market for Straumann, followed by North America and the Asia-Pacific region. These markets are crucial for the company's growth as they exhibit high demand for dental solutions. Expansion into emerging markets could offer further growth opportunities in the future.

Production Sites:

• Basel, Switzerland
• Villeret, Switzerland
• Andover, USA
• Curitiba, Brazil
• Beijing, China

Straumann Holding AG produces its products at several strategically important sites worldwide. The headquarters and a significant production site are located in Basel, Switzerland. Additional production facilities are located in Villeret, Switzerland, as well as in Andover, USA, Curitiba, Brazil, and Beijing, China. This geographical distribution enables Straumann to efficiently respond to demand in different markets and optimize supply chains.

Revenue Growth: 10.5% (2024) Profit Growth: 9.2% (2024)

Straumann Holding AG pursues a growth strategy based on several pillars. Firstly, the company heavily relies on innovation and research to expand its product range in the field of dental implantology and digital dentistry. This includes investments in new technologies and the development of new products that meet the needs of modern dentistry.

Secondly, Straumann focuses on geographical expansion, especially in emerging markets such as Asia and Latin America, where there is a growing demand for dental solutions. Through strategic partnerships and acquisitions in these regions, the company strengthens its market presence and taps into new customer segments.

Furthermore, Straumann places great emphasis on digitizing its processes and services. The implementation of digital solutions is intended to increase efficiency and improve customer service, leading to stronger customer loyalty. This strategy is supported by continuous training programs for dentists and specialized staff to promote the use of new technologies.

Main raw materials: Titanium, ceramics, precious metals

Countries of origin: USA, Japan, Germany, Switzerland

Straumann Holding AG is a leading provider of dental implants and dental solutions. The main raw materials imported by the company include titanium, ceramics, and precious metals. Titanium is an essential component for the production of dental implants due to its biocompatibility and strength. Ceramics are used for aesthetic and durable dental prosthetic solutions.

The USA and Japan are significant suppliers of titanium and ceramics, while Germany and Switzerland also represent important sources of high-quality materials and technologies. These countries not only provide the necessary raw materials but also offer advanced technologies and quality standards that are crucial for the production of dental solutions.

Market share: 25% in the global dental implant market (2024)

Research and development expenditure: CHF 200 million (2024)

Gross margin: 75% (2024)

Straumann Holding AG has a significant competitive advantage in the global dental implant market. With a market share of approximately 25%, the company is one of the leading providers in this sector. This strong market position is supported by continuous investments in research and development, amounting to CHF 200 million in 2024.

The high gross margin of 75% also indicates that Straumann is able to sell its products at a premium price, pointing to a strong brand perception and product differentiation. The company's innovation capabilities, combined with a wide product range and a strong global presence, further enhance its competitive advantage.

Additionally, Straumann benefits from strategic acquisitions and partnerships that expand its product portfolio and tap into new market segments. Together, these factors make Straumann one of the dominant players in the dental industry.

Institutional Investor Share: approximately 60% (estimated for 2025)

Insider Purchases/Sales: No specific data available for 2025

The institutional investor share in Straumann Holding AG traditionally stands at around 60%, based on historical data and typical market trends for companies of this size and industry. This reflects institutional investors' confidence in the company's long-term stability and growth potential.

Current data on insider purchases or sales are not specifically available for 2025. However, such transactions are usually considered as an indicator of management's confidence in the company's future development. It is advisable to regularly check the official announcements of Straumann Holding AG and financial platforms for up-to-date information.

Market share of Straumann Holding AG: approximately 25% (2025, estimated)

Top competitors and their market shares:

1. Straumann Holding AG: approximately 25%
2. Dentsply Sirona: approximately 20%
3. Nobel Biocare (Danaher Corporation): approximately 15%
4. Zimmer Biomet: approximately 10%
5. Henry Schein: approximately 8%
6. Osstem Implant: approximately 7%
7. BioHorizons: approximately 5%
8. MIS Implants Technologies: approximately 4%
9. Bicon Dental Implants: approximately 3%
10. Megagen Implant: approximately 3%

Moat of Straumann Holding AG:

Straumann Holding AG has a significant moat characterized by several factors. Firstly, the company has a strong brand recognition and an excellent reputation in the dental industry, particularly in the field of dental implants. This is supported by continuous innovations and investments in research and development, enabling Straumann to offer high-quality and technologically advanced products.

Secondly, Straumann has an extensive global distribution network and strong partnerships with dentists and clinics, facilitating market penetration and enhancing customer loyalty. These factors contribute to Straumann maintaining its leading position in the market.

Compared to its competitors, Straumann has the advantage of a wide range of products and a strong presence in high-growth markets. While companies like Dentsply Sirona and Nobel Biocare also have significant moats, particularly through their own innovation capabilities and market presence, Straumann remains in an advantageous position due to its strategic focus and market leadership.

Overall, Straumann has one of the strongest moats in the industry, which positively impacts its competitiveness and market position.

Revenue Growth: 10.5% (2024) EBITDA Margin: 30.2% (2024) Research & Development (R&D) Expenses: 7% of revenue (2024)

Straumann Holding AG was able to achieve a revenue growth of 10.5% in 2024, indicating strong demand for their dental products and solutions. The EBITDA margin of 30.2% demonstrates the company's solid profitability and efficient cost structure.

The ongoing investments in research and development, accounting for 7% of revenue, highlight Straumann's commitment to bringing innovative products to the market and securing its leadership position in the dental industry.

Furthermore, the company has expanded its global presence through strategic partnerships and acquisitions, enhancing growth potential in emerging markets. These factors suggest that Straumann is well positioned to benefit from long-term trends in the healthcare sector.

Overall, the stock of Straumann Holding AG appears to be an attractive investment based on its solid financial foundation and strategic focus on innovation and expansion.

Dividend Yield: 1.1% (2024)
Dividend History: Consistent payout in recent years

Straumann Holding AG has regularly distributed dividends in recent years. The dividend yield was around 1.1% in 2024, which is moderate compared to other companies in the dental industry.

The reliability of dividend payment is high as Straumann has a strong market position and solid financial foundations. The company has a history of stable and continuous dividend payments, indicating a conservative and sustainable dividend policy. Analysts expect that Straumann will continue to be able to pay dividends in the coming years, supported by its robust business model and continuous growth.